Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 4
2(50.0%)
4Total
N/A(2)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06574425Phase 4Enrolling By Invitation

Long-term, High Blood Flow Hemoadsorption Therapy in Patients Undergoing Maintenance Hemodialysis

Role: lead

NCT01640184Not ApplicableCompleted

Efficacy and Safety of Ultrasonic Ablation to Treat Secondary Hyperparathyroidism in Chronic Kidney Disease Patients

Role: lead

NCT01633853Phase 4Completed

Efficacy of Vitamin D2 to Treat Chronic Kidney Disease Mineral and Bone Disorder

Role: lead

NCT01642459Not ApplicableTerminated

The Outcomes of Arteriovenous Fistula Cannulated From Different Direction.

Role: lead

All 4 trials loaded